A landmark study is being conducted in Las Vegas to determine the effect of bexarotene, an established skin cancer drug, on patients with Alzheimer's disease. The trial was initiated after the drug was linked to cognitive improvements in mice. Patients will undergo brain imaging to assess changes in their neurological condition.
Researchers test skin cancer drug for Alzheimer's treatment
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan
|Vice President of Finance||
Urban Health Plan, Inc.
|Director of Payor/Provider Contracting||
U.S. Medical Management